Payden & Rygel Mckesson Corp Transaction History

Payden & Rygel

$1.44 Billion
Q4 2023

A detailed history of Payden & Rygel transactions in Mckesson Corp stock. As of the latest transaction made, Payden & Rygel holds 20,400 shares of MCK stock, worth $9.9 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

20,400

Holding current value

$9.9 Million

% of portfolio

0.66%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Feb 12, 2024	BUY	$437.42 - $470.64 $8.92 Million - $9.6 Million	20,400 New	20,400 $9.45 Million

Others Institutions Holding MCK

# of Institutions

1,754

Shares Held

111M

Call Options Held

871K

Put Options Held

902K

Vanguard Group Inc Valley Forge, PA

12M
Shares

$5.82 Billion
0.14% of portfolio
Black Rock Inc. New York, NY

11.5M
Shares

$5.57 Billion
0.15% of portfolio
State Street Corp Boston, MA

5.95M
Shares

$2.89 Billion
0.15% of portfolio
Massachusetts Financial Services CO Boston, MA

4.8M
Shares

$2.33 Billion
0.89% of portfolio
Jpmorgan Chase & CO New York, NY

4.5M
Shares

$2.18 Billion
0.23% of portfolio

View Full List

About MCKESSON CORP

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $69.8B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

More about MCK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Payden & Rygel, based on Form 13F filings with the SEC.

News

Stay updated on Payden & Rygel with notifications on news.

Account